Catheter Precision, Inc. (VTAK) is a publicly traded Healthcare sector company. As of May 21, 2026, VTAK trades at $0.80 with a market cap of $2.23M and a P/E ratio of -0.05. VTAK moved -3.83% today. Year to date, VTAK is -61.62%; over the trailing twelve months it is -85.28%. Its 52-week range spans $0.75 to $33.06. Rallies surfaces VTAK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
VTAK financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. VTAK recently traded at $0.80. Market cap is $2.23M. P/E ratio is -0.05. Revenue is $819.00K.
| Metric | Value |
|---|---|
| Price | $0.80 |
| Market Cap | $2.23M |
| P/E Ratio | -0.05 |
| EPS | $-15.90 |
| Dividend Yield | 0.00% |
| 52-Week High | $33.06 |
| 52-Week Low | $0.75 |
| Volume | 572 |
| Avg Volume | 0 |
| Revenue (TTM) | $819.00K |
| Net Income | $-17.70M |
| Gross Margin | 92.31% |
| Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $819.00K | $-17.70M | $-15.90 |
| 2024 | $420.00K | $-16.64M | $-6.68 |
| 2023 | $442.00K | $-70.57M | $0.00 |
VTAK analyst coverage data. Average price target: $0.00.